Senesco resolves NYSE Amex continued listing deficiency

Senesco Technologies, Inc. ("Senesco" or the "Company") (NYSE Amex: SNT) today announced that the Company has received a letter from the NYSE Amex LLC (the Exchange) informing Senesco that it has now resolved matters related to the Company's exchange listing compliance.

The letter stated that based upon a review of publicly available information, the Company has resolved the continued listing deficiency with respect to Section 1003(a)(iii) of the NYSE Amex LLC Company Guide referenced in the Exchange's letter dated October 29, 2009. The Exchange also indicated that, as is the case for all listed issuers, the Company's continued listing eligibility will be assessed on an ongoing basis and that the Company is subject to the provisions of Section 1009(f) of the NYSE Amex Company Guide, which may be accessed at www.nyse.com/regulation.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.